Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, antimalarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic.
Vaishali Pharma Limited (VAISHALI) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The VAISHALI share price is ₹6.94 (+1.91% today), with a market capitalisation of ₹91Cr. MarketRipple tracks the VAISHALI investment thesis, the ripple-chain impact of market events on Vaishali Pharma Limited, and the Healthcare sector outlook.
Open
₹6.82
High
₹7.05
Low
₹6.72
Prev. Close
₹6.81
52W High
₹9.90
52W Low
₹4.75
Day range
₹6.72–₹7.05
52-week range
₹4.75–₹9.90
Volume
35K
P/E
—
ROE
5.8%
D/E
0.27
Margin
4.1%
Vaishali Pharma Limited (NSE: VAISHALI) is currently trading at ₹6.94 (+1.91%).
Vaishali Pharma Limited's market capitalization is ₹91Cr.
Vaishali Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).